Brain Scientific Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRSF research report →
Price Chart
About the company
Brain Scientific Inc. , a medical technology enterprise established in 2013 and based in Sarasota, Florida, delivers neurology-focused medical devices and electric motors across the United States. The company further engages in the development of sophisticated motor platforms, an exceptionally precise micro-dosing pump, and various motion control products.
- CEO
- Hassan Kotob
- IPO
- 2021
- Employees
- 11
- HQ
- Sarasota, FL, US
Get TickerSpark's AI analysis on BRSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $746
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.27
- Div Yield
- 0.00%
- Gross Margin
- 25.32%
- Op Margin
- -4478.11%
- Net Margin
- -5753.00%
- ROE
- -681.55%
- ROIC
- -133.81%
Latest fiscal year · YoY change
- Revenue
- $214.56K-19.3%
- Gross Profit
- $54.33K-34.7%
- Op Income
- $-9,608,407
- Net Income
- $-12,343,858-35.6%
- EPS
- $-12.95+48.6%
- OCF Growth
- -1.2%
- FCF Growth
- -0.7%
- 52W High
- $0.75
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.59
- RSI (14)
- 83
- Avg Volume
- 101
No earnings-call transcripts are available for BRSF yet.
- Free Float
- 70.7%
- Shares Outstanding
- 1.24M
- Float Shares
- 878.01K
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 3, 22 | Cloutier Daniel Danny | other | 362,069 |
| Aug 19, 22 | Cloutier Daniel Danny | other | 304,608 |
| Nov 8, 21 | Cloutier Daniel Danny | other | 0 |
| Aug 19, 22 | Olivier Thomas | other | 304,608 |
| Aug 19, 22 | MacKenzie Donald S | other | 304,608 |
| Aug 19, 22 | Kukekov Nickolay V. | other | 304,608 |
| Aug 19, 22 | Kukekov Nickolay V. | other | 304,608 |
| Aug 19, 22 | Anthony Farid | other | 42,857 |
| Aug 19, 22 | Kotob Hassan | other | 22,930,987 |
| Aug 19, 22 | Gerety Bonnie-Jeanne | other | 1,293,150 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BRSF coverage
Recent articles, reports, and earnings notes.
No research on BRSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BRSF report →Tiziana Life Sciences presents intranasal foralumab at Preserving the Brain scientific conference in Italy
proactiveinvestors.ca · Sep 28
Brain Scientific and Piezo Motion Complete Merger and Announce Hassan Kotob as CEO of the Combined Company
globenewswire.com · Oct 4
Brain Scientific Enters into Merger Agreement with Piezo Motion
globenewswire.com · Jun 16
Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset
globenewswire.com · Mar 12
Brain Scientific Announces FDA Clearance for Next-Gen NeuroCap™ EEG Headset
globenewswire.com · Mar 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.